[go: up one dir, main page]

DE3869590D1 - Mischung zur behandlung von hypercholesterolemie. - Google Patents

Mischung zur behandlung von hypercholesterolemie.

Info

Publication number
DE3869590D1
DE3869590D1 DE8888202933T DE3869590T DE3869590D1 DE 3869590 D1 DE3869590 D1 DE 3869590D1 DE 8888202933 T DE8888202933 T DE 8888202933T DE 3869590 T DE3869590 T DE 3869590T DE 3869590 D1 DE3869590 D1 DE 3869590D1
Authority
DE
Germany
Prior art keywords
hypercholesterolemy
treating
mixture
treating hypercholesterolemy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888202933T
Other languages
English (en)
Inventor
Charles David Broaddus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Application granted granted Critical
Publication of DE3869590D1 publication Critical patent/DE3869590D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
DE8888202933T 1987-12-29 1988-12-19 Mischung zur behandlung von hypercholesterolemie. Expired - Lifetime DE3869590D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13897687A 1987-12-29 1987-12-29
US14203788A 1988-01-11 1988-01-11

Publications (1)

Publication Number Publication Date
DE3869590D1 true DE3869590D1 (de) 1992-04-30

Family

ID=26836745

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888202933T Expired - Lifetime DE3869590D1 (de) 1987-12-29 1988-12-19 Mischung zur behandlung von hypercholesterolemie.

Country Status (10)

Country Link
EP (1) EP0323666B1 (de)
JP (1) JP2664753B2 (de)
KR (1) KR970011070B1 (de)
AU (1) AU629193B2 (de)
CA (2) CA1340804C (de)
DE (1) DE3869590D1 (de)
DK (1) DK167736B1 (de)
IE (1) IE61514B1 (de)
IL (1) IL88745A (de)
NZ (1) NZ227474A (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95574A (en) * 1989-09-09 1994-11-11 Knoll Ag Colestyramine preparation
US5126150A (en) * 1990-10-01 1992-06-30 The Procter & Gamble Company Compositions containing psyllium
KR100221396B1 (ko) * 1990-12-20 1999-09-15 데이비드 엠 모이어 미감이 개선된, 질경이와 콜레스티라민의 조성물
US5576306A (en) * 1991-03-01 1996-11-19 Dow Chemical Company Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers
US5721221A (en) * 1991-03-08 1998-02-24 Regents Of The University Of Minnesota Lowering blood cholesterol levels using water soluble cellulose ethers
US5281584A (en) * 1992-02-28 1994-01-25 The Dow Chemical Company Effect of particle-size distribution of cellulose ethers on palatability of compositions
US5258181A (en) * 1992-03-02 1993-11-02 The Procter & Gamble Company Compositions containing psyllium
CZ218394A3 (en) * 1992-03-11 1995-01-18 Procter & Gamble Plantain drinking mixtures containing granulated base
WO1993018756A1 (en) * 1992-03-20 1993-09-30 The Procter & Gamble Company Anion exchange resin compositions
US5234916A (en) * 1992-06-12 1993-08-10 The Proctor & Gamble Company Psyllium drink mix compositions
US5232698A (en) * 1992-06-12 1993-08-03 The Proctor & Gamble Company Psyllium drink mix compositions
US5338549A (en) * 1992-12-21 1994-08-16 The Procter & Gamble Company Powdered psyllium drink mix compositions containing antioxidant
US5662934A (en) * 1993-01-05 1997-09-02 Najarian; Thomas Compositions and methods for lowering cholesterol while maintaining antioxidant levels
US5422101A (en) * 1993-05-14 1995-06-06 The Procter & Gamble Company Cholesterol lowering drink mix compositions
US5766638A (en) * 1995-12-08 1998-06-16 The Dow Chemical Company Hydroxypropyl methocellulose ether compositions for reduction of serum lipid levels
NZ595865A (en) * 2005-10-07 2011-12-22 Colocaps Pty Ltd Preparation for the Treatment of Diarrhoea comprising a bulking agent and diphenoxylate (ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylate)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1181003A (en) * 1967-03-20 1970-02-11 Mead Johnson & Co Therapeutic Compositions
US4778676A (en) * 1985-12-20 1988-10-18 Warner-Lambert Company Confectionery delivery system for actives

Also Published As

Publication number Publication date
DK728688D0 (da) 1988-12-29
CA1340804C (en) 1999-10-26
IE61514B1 (en) 1994-11-16
EP0323666B1 (de) 1992-03-25
JPH01294628A (ja) 1989-11-28
DK728688A (da) 1989-06-30
NZ227474A (en) 1991-06-25
KR900009088A (ko) 1990-07-02
AU629193B2 (en) 1992-10-01
DK167736B1 (da) 1993-12-13
IE883878L (en) 1989-06-29
CA1340836C (en) 1999-11-30
IL88745A (en) 1992-12-01
JP2664753B2 (ja) 1997-10-22
KR970011070B1 (ko) 1997-07-07
AU2748788A (en) 1989-06-29
IL88745A0 (en) 1989-07-31
EP0323666A1 (de) 1989-07-12

Similar Documents

Publication Publication Date Title
DE3884622D1 (de) Schmiermittelzubereitung zur behandlung von rheuma.
DE68907909D1 (de) Praeparat zur behandlung von erektionsstoerungen.
DE3584013D1 (de) Zubereitung zur behandlung von psoriasis.
DE3580918D1 (de) Anordnung zur behandlung von bildern.
DE3772429D1 (de) Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten.
DE3775597D1 (de) Vorrichtung zur behandlung von teilchenfoermigem material.
DE3752141D1 (de) Mittel zur behandlung von neuropathie
DE3869490D1 (de) Verfahren zur elektrochemischen behandlung von stoffen.
DE3789053D1 (de) Vorrichtung zur Behandlung von Hypertrophie der Vorsteherdrüse.
DE3581514D1 (de) Film zur behandlung von halbleiterwaffeln.
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
DE3882775D1 (de) Zusammensetzung zur behandlung von parodontaler krankheit.
DE3677520D1 (de) Vorrichtung zur behandlung von behaeltern.
DE3869590D1 (de) Mischung zur behandlung von hypercholesterolemie.
DE3481277D1 (de) Vorrichtung zur behandlung von gas-fluessigkeitsgemischen.
DE3681642D1 (de) Benzopyran-verbindungen zur behandlung von inkontinenz.
DE3885460D1 (de) Vorrichtung zur behandlung von flüssigkeiten.
DE3669664D1 (de) Vorrichtung zur behandlung von fluessigkeiten.
DE3768459D1 (de) Duese zur zufuhr von behandlungsdraht.
DE3875016D1 (de) Therapeutikum zur behandlung von aids.
DE68903208D1 (de) Verfahren zur thermischen behandlung von laktoferrin.
DE3761377D1 (de) Verfahren zur aufarbeitung von 2-merkaptobenzthiazol enthaltenden teeren.
DE3751510D1 (de) Düse zur Behandlung von Fäden.
DE3577550D1 (de) Aminocarbonsaeurekomplexe zur behandlung von knochentumoren.
DE3886755D1 (de) Verfahren zur behandlung von gefässkrankheiten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee